ClinicalTrials.Veeva

Menu

Evaluation of Fusion After ALIF With an Osteoinductive Material or With Homologus Bone

J

Johann Wolfgang Goethe University Hospital

Status

Completed

Conditions

Fusion of Spine, Lumbar Region

Treatments

Device: Homologous Bone
Device: NanoBone

Study type

Interventional

Funder types

Other

Identifiers

NCT03331159
NanoBone - ALIF

Details and patient eligibility

About

The aim of this study was to determine whether instrumented anterior lumbar interbody Fusion with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2) was associated with superior radiological and clinical outcomes at 12 months follow-up compared with instrumented ALIF with homologous bone

Full description

This randomized clinical trial included two groups of 20 mature patients with mono- or multisegmental degenerative disease of the lumbar spine who were suitable to undergo mono- or bisegmental ALIF fusion at the level L4/L5 and L5/S1 with a carbon fiber reinforced polymer ALIF cage filled with either NH-SiO2 or homologous bone (HB). Patients were followed 12 months postoperatively. The primary aim was to compare postoperative disability as measured by the Oswestry Disability Index (ODI). Secondary aims were to compare postoperative radiographic outcomes and differences in pain and quality of life between these groups.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic low back pain
  • sensorimotor deficits
  • radiculopathy and spinal claudication symptoms, all caused by degenerative changes in the lumbar spine, which were resistant to conservative pain therapy and / or physiotherapy

Exclusion criteria

  • previous surgeries in the abdominal Region
  • previous fusion surgery in the lumbar spine.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

NanoBone
Experimental group
Description:
The participants were treated with anterior lumbar interbody fusion (ALIF) with a new nanocrystalline hydroxyapatite embedded in a silica gel matrix (NH-SiO2)
Treatment:
Device: NanoBone
Homologous bone
Active Comparator group
Description:
The participants were treated with anterior lumbar interbody fusion (ALIF) with homologous bone
Treatment:
Device: Homologous Bone

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems